Racura Oncology Ltd

NEW
FRA:FN3 (Australia)  
€ 1.28 -0.030 (-2.29%) Sep 3
At Loss
P/B:
11.25
Market Cap:
€ 259.45M ($ 300.89M)
Enterprise V:
€ 238.25M ($ 276.30M)
Volume:
0
Avg Vol (2M):
0
Trade In:

Racura Oncology Ltd (FRA:FN3) Dividend

Racura Oncology Ltd (FRA:FN3) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -6.3%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: FRA:FN3 Dividend

Does Racura Oncology Ltd (FRA:FN3) pay a dividend?

Racura Oncology Ltd (FRA:FN3) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Racura Oncology Ltd pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Racura Oncology Ltd has returned capital to shareholders via buybacks at a rate of -6.3% over the past 3 years.

What are dividend-paying alternatives to Racura Oncology Ltd?

For dividend-paying alternatives in Racura Oncology Ltd's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.